Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
journalStr:"Nature communications"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=journalStr%3A%22Nature+communications%22&lookfor=%22Antiviral+Agents%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=journalStr%3A%22Nature+communications%22&lookfor=%22Antiviral+Agents%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=journalStr%3A%22Nature+communications%22&lookfor=%22Antiviral+Agents%22&type=Subject
PubPharm (90)
1
Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2
enthalten in:
Nature communications
| 2024
von
Lee, D.
|
Jung, H.
|
Park, D.
| +12
Wird geladen...
2
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
enthalten in:
Nature communications
| 2024
von
Standing, J.
|
Buggiotti, L.
|
Guerra-Assuncao, J.
| +51
Wird geladen...
3
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
enthalten in:
Nature communications
| 2024
von
Leng, L.
|
Xu, Z.
|
Hong, B.
| +25
Wird geladen...
4
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets
enthalten in:
Nature communications
| 2024
von
Cox, R.
|
Wolf, J.
|
Lieberman, N.
| +16
Wird geladen...
5
Antiviral fibrils of self-assembled peptides with tunable compositions
enthalten in:
Nature communications
| 2024
von
Dodd-O, J.
|
Roy, A.
|
Siddiqui, Z.
| +21
ErratumIn: Nat Commun. 2024 Feb 19;15(1):1505. - PMID 38374216
Wird geladen...
6
EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses
enthalten in:
Nature communications
| 2024
von
Pan, Q.
|
Xie, Y.
|
Zhang, Y.
| +4
Wird geladen...
7
Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection
enthalten in:
Nature communications
| 2024
von
Hou, J.
|
Wei, Y.
|
Zou, J.
| +18
UpdateOf: Res Sq. 2022 Aug 15;:. - PMID 36032971
Wird geladen...
8
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis : target trial emulation
enthalten in:
Nature communications
| 2023
von
Wong, C.
|
Lau, J.
|
Au, I.
| +5
Wird geladen...
9
Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs
enthalten in:
Nature communications
| 2023
von
Han, A.
|
Hannay, E.
|
Carmona, S.
| +3
UpdateOf: medRxiv. 2023 Oct 13;:. - PMID 36238715
Wird geladen...
10
Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry
enthalten in:
Nature communications
| 2023
von
Wang, H.
|
Yang, Q.
|
Liu, X.
| +19
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Nature communications
Medienart
90
Aufsätze
90
E-Artikel
90
E-Ressourcen
Zeitschriftentitel
Nature communications
Thema
90
Antiviral Agents
90
Journal Article
71
Research Support, Non-U.S. Gov't
26
Research Support, N.I.H., Extramural
14
Spike Glycoprotein, Coronavirus
13
Protease Inhibitors
13
Research Support, U.S. Gov't, Non-P.H.S.
12
Antibodies, Viral
12
EC 3.4.22.-
11
Coronavirus 3C Proteases
11
EC 3.4.22.28
11
spike protein, SARS-CoV-2
8
Antibodies, Neutralizing
8
Peptides
8
Viral Nonstructural Proteins
7
3C-like proteinase, SARS-CoV-2
7
EC 3.4.-
7
Interferon Type I
5
3QKI37EEHE
5
ACE2 protein, human
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2024
23
2023
23
2022
24
2021
13
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
90
Englisch
Haven't found what you're looking for?
Wird geladen...